PMA device
Acuity Spiral Leads
Boston Scientific Corp · Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode (OJX, Class III) · First FDA decision Mar 19, 2015, newest Mar 19, 2015Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
2
Naming "Acuity Spiral"
MAUDE reports
360
Brand "Acuity Spiral", since 2015
PubMed studies
0
Mentioning "Acuity Spiral"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Acuity Spiral Leads
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- ACUITY SPIRAL LEADSPMA supplement
P010012-S383 · Decided Mar 19, 2015 · 87 days after receipt · Normal 180 Day Track
Device type: Drug eluting permanent left ventricular (lv) pacemaker electrode (OJX) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Pacemakers: Single-Chamber and Dual-Chamber Permanent Cardiac PacemakersNational analysisReview closedCAG-00063R3Updated Sep 17, 2026
- Single Chamber and Dual Chamber Permanent Cardiac PacemakersNational determinationOn the books20.8.3Updated Dec 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Acuity Spiral", any status and sponsor, newest update first.
Boston Scientific CorporationPublic (BSX)
NCT02071173 · 2,244 participants · Start Apr 14, 2014 · Primary completion Apr 19, 2017
Device: ACUITY X4 quadripolar coronary venous lead and RELIANCE 4-FRONT defibrillation lead · For: Cardiac Resynchronization Therapy
Sites: Birmingham, Alabama; Huntsville, Alabama; Anchorage, Alaska · 96 sites in all
Boston Scientific CorporationPublic (BSX)
NCT00955708 · 1,308 participants · Start Aug 4, 2009 · Primary completion Feb 28, 2018
Device: ACUITY Spiral Left Ventricular Lead · For: Heart Failure
Sites: Birmingham, Alabama; Anchorage, Alaska; Mesa, Arizona · 97 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Acuity Spiral", and for the whole product code for context.
This brand
360 reports: 70 malfunction, 289 injury, 1 death
Whole product code OJX
40,615 reports: 16,946 malfunction, 22,305 injury, 1,330 death
Newest reports for this brand
- ACUITY SpiralInjury
2124215-2026-56826 · Received Oct 26, 2026 · Event dated Jan 22, 2020
Device type: Implantable Pulse Generator, Pacemaker (Non-Crt) (LWP)
Device problem as coded: Signal Artifact/Noise; Failure to Capture
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ACUITY? SpiralInjury
2124215-2026-55861 · Received Oct 21, 2026 · Event dated Sep 30, 2026
Device type: Implantable Pulse Generator, Pacemaker (Non-Crt) (LWP)
Device problem as coded: Signal Artifact/Noise; Failure to Capture; Over-Sensing; Off-Label Use; High Capture Threshold
Patient problem as coded: Bradycardia
- ACUITY? SpiralInjury
2124215-2026-53742 · Received Oct 9, 2026 · Event dated Sep 22, 2026
Device type: Implantable Pulse Generator, Pacemaker (Non-Crt) (LWP)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1671-2022 · Started Jul 7, 2022
Reason given: There is potential for unanticipated software anomalies to occur when using the Model 2868 Application loaded on the 3120 ZOOM LATITUTDE programmer when communicating with certain Boston Scientific transvenous defibrillators.
Cause as FDA categorized it: Under Investigation by firm · Device type: Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK)
Z-0079-2018 · Started Oct 4, 2017
Reason given: The devices have an incorrect firmware configuration.
Cause as FDA categorized it: Under Investigation by firm · Device type: Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK)
- MOMENTUM X4 CRT-D, Model G138, Sterile.Terminated
Z-0080-2018 · Started Oct 4, 2017
Reason given: The devices have an incorrect firmware configuration.
Cause as FDA categorized it: Under Investigation by firm · Device type: Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK)
16 more recall records with a free account
Published research
The most relevant PubMed records for "Acuity Spiral"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OJX.
- Medtronic Attain Ability Model 4196 LeadMedtronic, Inc. · PMA 2020
- Attain StarFix Model 4195 LeadMedtronic, Inc. · PMA 2018
- Attain Ability Straight Left Ventricular LeadMedtronic, Inc. · PMA 2021
- Consulta Crt-P, Syncra CRT-PMedtronic, Inc. · PMA 2013
- Medtronic Attain Ability Plus Left Ventricular LeadMedtronic, Inc. · PMA 2019
- Attain Performa Model 4398 and 4598 Left Ventricular LeadsMedtronic, Inc. · PMA 2014
- Insync Crt-P/Insync III CRT-PMedtronic, Inc. · PMA 2011
- Attain Stability Quad MRI SureScan LeadMedtronic, Inc. · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.